Search

IUPAC name of enfuvirtide vs rasagiline

Input interpretation

enfuvirtide rasagiline | IUPAC name
enfuvirtide rasagiline | IUPAC name

Results

enfuvirtide | (4S)-4-[[(2S, 3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S, 3S)-2-[[(2S)-2-[[(2S)-2-[[(2S, 3R)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-amino-3-cyclohexyl-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1, 4-dioxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-hydroxy-1, 4-dioxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-1, 4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-1, 4-dioxobutan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-5-oxopentanoic acid rasagiline | (1R)-N-prop-2-ynyl-2, 3-dihydro-1H-inden-1-amine
enfuvirtide | (4S)-4-[[(2S, 3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S, 3S)-2-[[(2S)-2-[[(2S)-2-[[(2S, 3R)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-amino-3-cyclohexyl-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1, 4-dioxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-hydroxy-1, 4-dioxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-1, 4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-1, 4-dioxobutan-2-yl]amino]-1, 5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-hydroxy-1, 5-dioxopentan-2-yl]amino]-5-oxopentanoic acid rasagiline | (1R)-N-prop-2-ynyl-2, 3-dihydro-1H-inden-1-amine

Random Queries

DOT hazard class of gallium
CAS number of cerium(III) orthovanadate
melting point of iron vs chromium
freezing point of thallium(I) azide vs sodium hexanitroiridate(III)
alternate names of titanium(IV) ions
InChI key of dimethyl(4R,5 R)-1,3,2-dioxathiolane-4,5-dicarboxylate 2,2-dioxide
CAS copper iron oxide
freezing point of gallium(III) perchlorate hydrate vs iodoethane-2-13 C
formula of potassium iodide vs lithium sulfate
molar mass of gallium(III) cation vs fluoride anion